greenbook2

1

√“¬™Ë◊Õº≈µ‘ ¿≥— ±å¬“§ÿ≥¿“æ·≈–ºŸºâ ≈‘µ ‡≈¡à ∑Ë’ 2 æ.».2549 ∑ª’Ë √°÷ …“ πæ.‰æ®‘µ√å «√“™‘µ Õ∏‘∫¥’°√¡«‘∑¬“»“ µ√å°“√·æ∑¬å πæ.Õ”π«¬ °“®’π– √ÕßÕ∏‘∫¥’°√¡«‘∑¬“»“ µ√å°“√·æ∑¬å æ≠.¡¬ÿ√“ °ÿ ÿ¡¿å π—°«‘∑¬“»“ µ√å°“√·æ∑¬å 11 ™™ ¥â“π«‘®—¬«‘∑¬“»“ µ√å “∏“√≥ ÿ¢ ¿≠.¥√. ®ß¥’ «àÕßæ‘π—¬√—µπå π—°«‘∑¬“»“ µ√å°“√·æ∑¬å 10 ™™ ¥â“π«‘®—¬·≈–æ—≤π“«‘∑¬“»“ µ√å°“√·æ∑¬å (¡“µ√∞“πÀâÕߪؑ∫—µ‘°“√) ¿≠.¥«ßæ√ Õ¿‘°—πµæ—π∏å ºŸâÕ”π«¬°“√ ”π—°¬“·≈–«—µ∂ÿ‡ æµ‘¥ ¿≠.π—π∑π“  ‘∑∏‘™—¬ ‡¿ —™°√ 9 «™ ¥â“πª√– ‘∑∏‘¿“æ¢Õ߬“ §≥–ºŸâ®—¥∑” ¿≠. ÿ¢»√’ Õ÷Èß∫√‘∫√Ÿ ≥å‰æ»“≈ ‡¿ —™°√ 8 «™ ¿°. ¡»—°¥‘Ï  ÿπ∑√æ“≥‘™¬å ‡¿ —™°√ 7 «™ ¿≠. “√‘π’ ‡≈π–æ—π∏å ‡¿ —™°√ 6 « ‡®“â ¢Õß  ”π—°¬“·≈–«—µ∂ÿ‡ æµ‘¥ °√¡«‘∑¬“»“ µ√å°“√·æ∑¬å °√–∑√«ß “∏“√≥ ÿ¢ ‚∑√.0-2951-0000 µàÕ 99156 ‚∑√ “√.0-2580-5733 2 æ¡‘ æ∑å Ë’ ‚√ßæ‘¡æå ”π—°ß“πæ√–æÿ∑∏»“ π“·Ààß™“µ‘ ‡≈à¡∑’Ë 2 æ‘¡æå®”π«π 5,000 ‡≈à¡ ªï∑’Ëæ‘¡æå æ.».2549 ISBN : 974-7549-72-7

§”π” 3 °√¡«‘∑¬“»“ µ√å°“√·æ∑¬å‰¥â¥”‡π‘π°“√µ√«® Õ∫§ÿ≥¿“æ·≈–§«“¡ ª≈Õ¥¿¬— ¢Õ߬“„π‚§√ß°“√ √“â ßÀ≈°— ª√–°π— §≥ÿ ¿“æ·≈–¡“µ√∞“π∫√°‘ “√¥“â 𬓠¢Õß°√–∑√«ß “∏“√≥ ÿ¢ ¿“¬„µâ§«“¡√à«¡¡◊Õ¢Õß ”π—°ß“π “∏“√≥ ÿ¢®—ßÀ«—¥ ‚√ß欓∫“≈¢Õß√∞—  ”π°— ß“π§≥–°√√¡°“√Õ“À“√·≈–¬“ ¡“µß—È ·µªà ï 2545 ¿“¬ „µ‚â §√ß°“√¥ß— °≈à“«‰¥â°”Àπ¥À≈°— ‡°≥±«å à“ µ”√∫— ¬“∑º’Ë à“π°“√µ√«®«‡‘ §√“–À‡å ¢“â ¡“µ√∞“π∑—ÈßÀ¡¥ ·≈–ºà“πÕ¬à“ßπâÕ¬ 3 √ÿàπ°“√º≈‘µ ‚¥¬ à«π„À≠à„™â«‘∏’·≈– ¡“µ√∞“πµ“¡µ”√“¬“©∫—∫∑Ë’√—∞¡πµ√’ª√–°“»À√◊Õ©∫—∫„À¡à°«à“ ®–‰¥â√—∫°“√ §—¥‡≈◊Õ°‡ªìπµ”√—∫¬“§ÿ≥¿“æ¡“‡º¬·æ√à ´÷Ëߺ≈°“√¥”‡π‘πß“π„πªïß∫ª√–¡“≥ æ.».2545-2547 ‰¥âπ”¡“√«∫√«¡·≈–√“¬ß“π‰«â„πÀπ—ß ◊Õ√“¬™Ë◊Õº≈‘µ¿—≥±å¬“ §ÿ≥¿“æ·≈–ºŸâº≈‘µ (Green Book) ‡≈à¡·√° æ.».2548 ‚¥¬· ¥ß™Ë◊Õ “¡—≠ ∑“߬“ ™◊ËÕºŸâº≈µ‘ ‡≈¢∑–‡∫’¬π¬“ ™◊ÕË ∑“ß°“√§â“ ¢π“¥§«“¡·√ߢÕßµ—«¬“ ”§—≠ ·≈–À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“扫⠇æË◊Õ‡º¬·æ√à‡ªìπ¢âÕ¡Ÿ≈„À⺟⇰’ˬ«¢âÕß√—∫∑√“∫ ·≈–𔉪„™âª√–‚¬™πå„π°“√∫√‘À“√¬“·≈–æ—≤π“°“√º≈‘µ¬“ Àπ—ß Õ◊ ¥ß— °≈à“«‰¥â √—∫°“√µÕ∫√—∫∑’¥Ë ’ ºâŸº≈‘µµ√–Àπ°— ∑’®Ë –æ≤— 𓬓·µ≈à –µ”√—∫Õ¬à“ß®√ß‘ ®ß— ‡æËÕ◊ º≈µ‘ ÕÕ°®”Àπà“¬‚¥¬‰¡à®”‡ªìπµâÕß¡’À≈“¬‡≈¢∑–‡∫’¬π„π Ÿµ√µ”√—∫‡¥’¬«°—π Õ’° ∑Èß— ‰¥â√—∫¢Õâ ‡ πÕ·π–∑Ë’‡ªìπª√–‚¬™π®å “°À≈“¬Ω“É ¬∑‡Ë’ °¬Ë’ «¢Õâ ß Àπ—ß Õ◊ √“¬™◊ËÕº≈‘µ¿—≥±å¬“§ÿ≥¿“æ·≈–ºŸºâ ≈‘µ ‡≈¡à ∑’Ë 2 (Green Book 2) πÈ’ ®—¥∑”¢÷Èπ„π·π«∑“߇¥’¬«°—π°—∫‡≈à¡·√° ‚¥¬π”√“¬™Ë◊Õµ”√—∫¬“§ÿ≥¿“æ ∑’Ë ºà“π°“√µ√«®«‘‡§√“–Àå„πªïß∫ª√–¡“≥ 2548 ®“°‚§√ß°“√ √â“ßÀ≈—°ª√–°—π §ÿ≥¿“æ·≈–¡“µ√∞“π∫√‘°“√¥â“𬓠¢Õß°√¡«‘∑¬“»“ µ√å°“√·æ∑¬å ·≈– ‚§√ß°“√ª√–°—π§ÿ≥¿“欓∑’Ë„™â„π‚√ß欓∫“≈™ÿ¡™π·≈–Àπ૬∫√‘°“√ª∞¡¿Ÿ¡‘ ∑Ë’‰¥â√—∫°“√ π—∫ πÿπß∫ª√–¡“≥®“° ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ·Ààß™“µ‘ ¡“√“¬ß“π‰«âæ√âÕ¡¢âÕ¡Ÿ≈Õ◊Ëπ∑’ˇ°Ë’¬«¢âÕß ·≈–„π¿“§ºπ«° ‰¥âπ”¢âÕ°”Àπ¥ ¿“™π–∫√√®ÿ¬“™π‘¥·§ª´Ÿ≈·≈–¬“‡¡Á¥æ√âÕ¡µ”√—∫¬“∑Ë’„™â¿“™π–∫√√®ÿªî¥  π‘∑À√◊Õªî¥Õ¬à“ߥ’·≈–ªÑÕß°—π· ß ´÷Ë߇ªìπ√“¬™Ë◊Õµ”√—∫¬“∑Ë’√–∫ÿ„πµ”√“¬“ USP 29 - 2006 ¡“‡ πÕ ‡æË◊Õ‡ªì𧫓¡√⟄π°“√®—¥∫√√®ÿ¿—≥±å‡æË◊Õ®à“¬¬“„Àâ ºŸâªÉ«¬‰¥âÕ¬à“ß∂Ÿ°µâÕß ‡ªìπ°“√™à«¬√—°…“¬“„Àâ¡’§ÿ≥¿“æµ≈Õ¥Õ“¬ÿ°“√„™â ´Ë÷ß ‡™ÕË◊ «à“®–‡ªìπª√–‚¬™πÕå ¬“à ß¡“°µàÕ‡¿ ™— °√ °“√ª√–°π— §≥ÿ ¿“欓·≈–°“√ª√∫— ª√ßÿ ‡æ¡Ë‘ ‡µ¡‘ ¢Õâ ¡≈Ÿ √“¬™ÕË◊ º≈µ‘ ¿≥— ±å ¬“§ÿ≥¿“æ·≈–ºâŸº≈‘µ (Green Book) ‡≈ࡵàÕʉª¬—ߧ߇ªìπ¿“√°‘®∑’Ë°√¡ «‘∑¬“»“ µ√å°“√·æ∑¬å®–¥”‡π‘π°“√Õ¬à“ßµàÕ‡π◊ËÕ߇æ◊ËÕ √â“ߧ«“¡¡Ë—π„®„π°“√ ¥”‡ππ‘ °“√µ“¡π‚¬∫“¬À≈°— ª√–°π—  ¢ÿ ¿“æ·Àßà ™“µ¢‘ Õߺ√Ÿâ ∫— ∫√°‘ “√·≈–º Ÿâ ßË— „™¬â “ ·≈–À«—߇ªìπÕ¬à“ß¬Ë‘ß«à“ ¢âÕ¡Ÿ≈„πÀπ—ß ◊Õ‡≈à¡π’È®–‡ªìπª√–‚¬™πå„π°“√∫√‘∫“≈ ∑“߇¿ —™°√√¡µÕà ‰ª (𓬷æ∑¬å ‰æ®‘µ√å «√“™‘µ) Õ∏∫‘ ¥°’ √¡«‘∑¬“»“ µ√å°“√·æ∑¬å

  “ √ ∫— ≠ °“√®—¥∑”√“¬™◊ËÕº≈‘µ¿—≥±å¬“§ÿ≥¿“æ·≈–ºâŸº≈‘µ Àπâ“ Abstract 7 °‘µµ‘°√√¡ª√–°“» 9 √“¬™◊ËÕº≈‘µ¿—≥±å¬“§ÿ≥¿“æ·≈–ºŸâº≈‘µ ®”·π°µ“¡ª√–‡¿∑¢Õ߬“ 10 11 ¬“ªØ™‘ «’ π– 13 Cefaclor capsule 14 Cefaclor suspension 15 Cefdinir capsule 16 Ceftazidime for injection 17 Cefuroxime for injection 18 Chloramphenical ear drop 19 Chloramphenical eye drop 20 Clindamycin injection 21 Co-trimoxazole oral suspension 22 Dicloxacillin sodium capsule 23 24 4 Norfloxacin tablet 25 Penicillin V potassium dry syrup 26 Penicillin V potassium tablet 27 Roxithromycin tablet ¬“√°— …“‚√§À—«„® ≈¥§«“¡¥π— ‚≈À‘µ 29 Captopril tablet 30 Isosorbide dinitrate tablet 31

Nifedipine solf capsule Àπâ“ Nifedipine extended release tablet 32 Propranolol HCl film coated tablet 33 34 ¬“·°ªâ «¥ ≈¥‰¢â µ“â π°“√Õ°— ‡ ∫ §≈“¬°≈“â ¡‡π◊ÕÈ Aspirin tablet /enteric coated tablet 35 Diclofenac diethylammonium gel 36 Ibuprofen tablet 37 Naproxen sodium tablet 38 Naproxen tablet 39 Tolperisone HCl tablet 40 41 ¬“√°— …“‚√§„π√–∫∫∑“߇¥π‘ Õ“À“√ Domperidone oral suspension 43 Domperidone tablet 44 Hyoscine butylbromide coated tablet 45 Ranitidine tablet 46 47 ¬“√—°…“‚√§„π√–∫∫∑“߇¥‘πÀ“¬„® Salbutamol inhaler 49 Triprolidine HCl and pseudoephedrine HCl tablet 50 5 Terbutaline sulfate injection 51 Terbutaline sulfate tablet 52 53 ¬“√°— …“‚√§∑“ß√–∫∫ª√– “∑ Carbamazepine oral suspension 55 Diazepam tablet 56 Phenytoin capsule 57 58

¬“≈¥‰¢¡π— „πÀ≈Õ¥‡≈Õ◊ ¥ Àπâ“ Atorvastatin film coated tablet 59 60 ¬“√°— …“‡∫“À«“π Metformin HCl tablet 61 62 ¬“µâ“π‡™◊ÕÈ √“ Fluconazole capsule 63 64 ¬“ª√–‡¿∑Õπ◊Ë Ê Albendazole tablet 65 Dexamethasone injection 66 Dexamethasone tablet 67 Propylthiouracil tablet 68 Timolol maleate eye drop 69 70 ¿“§ºπ«° -¢âÕ°”Àπ¥¿“™π–∫√√®ÿ ”À√—∫¬“·§ª´≈Ÿ ·≈–¬“‡¡Á¥ 71 -µ”√—∫¬“∑’Ë„™â¿“™π–∫√√®ÿªî¥·πàπ·≈–ªÑÕß°—π· ß 72 74 6 (Tight, Light-resistance) -µ”√—∫¬“∑’Ë„™â¿“™π–∫√√®ÿªî¥Õ¬à“ߥ’·≈–ªÑÕß°—π· ß 81 (Well-closed, Light-resistance) -À—«¢âÕ∑¥ Õ∫„πº≈‘µ¿—≥±å¬“ ”‡√Á®√Ÿª 83 88 ¥√√™π’ (Index)

°“√®¥— ∑”√“¬™ËÕ◊ º≈µ‘ ¿≥— ±¬å “§≥ÿ ¿“æ·≈–ºâºŸ ≈µ‘ ‡≈¡à ∑Ë’ 2 °“√ª√–°π— §≥ÿ ¿“欓¢Õß°√¡«∑‘ ¬“»“ µ√°å “√·æ∑¬å ªßï ∫ª√–¡“≥ 7 2548 ‰¥¥â ”‡ππ‘ ‚§√ß°“√ √“â ßÀ≈°— ª√–°π— §≥ÿ ¿“æ·≈–¡“µ√∞“π∫√°‘ “√¥“â 𠬓 ‚¥¬µ√«®  Õ∫§ÿ≥¿“欓·ºπª®í ®ÿ∫π— ·≈–¬“®“° ¡πÿ ‰æ√ ®”π«π 36 √“¬°“√ ´ßË÷ ‡ªì𬓷ºπªí®®ÿ∫—π 34 √“¬°“√ (1 √“¬°“√ À¡“¬∂ß÷ 1 ™π¥‘ µ—«¬“ 1 √Ÿª·∫∫¬“) ·≈–¥”‡π‘π‚§√ß°“√ª√–°—π§ÿ≥¿“欓∑Ë’„™â„π‚√ß æ¬“∫“≈™¡ÿ ™π·≈–Àπ«à ¬ ∫√°‘ “√ª∞¡¿¡Ÿ ‘ ®“°°“√ π∫—  ππÿ ß∫ª√–¡“≥¢Õß  ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ·Ààß™“µ‘ ®”π«π 10 √“¬°“√ ‚¥¬ ÿà¡ µ—«Õ¬à“ߺ≈‘µ¿—≥±å¬“À≈—ß àß¡Õ∫ ®“°°“√®—¥´È◊Õ√à«¡„π®—ßÀ«—¥À√◊Õ‡¢µ´÷Ëß ‰¥â√—∫§«“¡√à«¡¡◊Õ„π°“√ ÿà¡ µ—«Õ¬à“ß®“°‚√ß欓∫“≈¢Õß√—∞∑—Ë«ª√–‡∑» º“à π ”π°— ß“π “∏“√≥ ¢ÿ ®ß— À«¥— ·≈–®“°‚√ß欓∫“≈πÕ° ß— °¥— °√–∑√«ß  “∏“√≥ ¢ÿ „π‡¢µ°√ßÿ ‡∑æ¡À“π§√ ‡æÕË◊  ßà µ√«®«‡‘ §√“–À∑å °’Ë √¡«∑‘ ¬“»“ µ√å °“√·æ∑¬å ‚¥¬ÀâÕߪؑ∫—µ‘°“√¢Õß  ”π—°¬“·≈–«—µ∂ÿ‡ æµ‘¥·≈–»Ÿπ¬å «∑‘ ¬“»“ µ√°å “√·æ∑¬å °“√µ√«® Õ∫§ÿ≥¿“愙⫑∏’·≈–¡“µ√∞“πµ“¡µ”√“¬“©∫—∫∑’Ë √—∞¡πµ√’ª√–°“»À√◊Õ©∫—∫„À¡à°«à“ „π∑ÿ°º≈‘µ¿—≥±å¬“∑Ë’¡’√Ÿª·∫∫¬“·≈– µ«— ¬“ ”§≠— ‡À¡Õ◊ π°π— ‡æÕ◊Ë ª√–‡¡π‘ §≥ÿ ¿“æ∫π¡“µ√∞“π‡¥¬’ «°π— ∑°ÿ ·À≈ßà º≈‘µ º≈°“√µ√«® Õ∫§ÿ≥¿“æ ‰¥â§—¥‡≈◊Õ°√“¬™◊ËÕµ”√—∫¬“∑Ë’ºà“π‡°≥±å ¡“µ√∞“π∑ÿ°µ—«Õ¬à“ßµ—Èß·µà 3 √ÿàπº≈‘µ¢È÷π‰ª¡“‡º¬·æ√à‚¥¬®”·π°µ“¡ ª√–‡¿∑¢Õ߬“ ¡’√“¬≈–‡Õ’¬¥¢Õß™Ë◊Õ “¡—≠∑“߬“ æ√âÕ¡√Ÿª·∫∫¬“ À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ ™Ë◊պ⟺≈‘µ ‡≈¢∑–‡∫’¬π¬“ ™Ë◊Õ∑“ß°“√§â“·≈– ¢π“¥§«“¡·√ß  ”À√—∫√“¬°“√¬“∑’ˉ¥â√—∫°“√ π—∫ πÿπß∫ª√–¡“≥®“°

 ”π°— ß“πÀ≈°— ª√–°—π ÿ¢¿“æ·Àßà ™“µ‘ ‰¥â√–∫‰ÿ «â„À∑â √“∫¥«â ¬ „π°“√¥”‡π‘π‚§√ß°“√¥—ß°≈“à « º≈ √ÿª¢Õß°“√¥”‡π‘π°“√‡æ◊ÕË §—¥ ‡≈Õ◊ °√“¬™Õ◊Ë º≈µ‘ ¿≥— ±¬å “§≥ÿ ¿“æ·≈–ººŸâ ≈µ‘ æ∫«“à ¬“∫“ßµ”√∫— (1 µ”√∫— À¡“¬∂÷ß 1 ‡≈¢∑–‡∫’¬π) ∂Ÿ° ¡ÿà µ√«®·≈–¡§’ ≥ÿ ¿“溓à π‡°≥±¡å “µ√∞“π ·µ‰à ¡§à √∫ 3 √πÿà º≈µ‘ µ“¡‡°≥±°å “√§¥— ‡≈Õ◊ °‡æÕ◊Ë ‡º¬·æ√„à π GREEN BOOK ‡≈à¡∑’Ë 2 ∫“ßµ”√—∫‰¡à‰¥â√—∫°“√ ÿࡵ√«®„π¢≥–π—Èπ À√◊Õ∫“ßµ”√—∫∂Ÿ° àÿ¡ µ√«®¡“°°«“à 3 √πÿà º≈µ‘ ·µ∫à “ß√πàÿ º≈µ‘ æ∫«“à §≥ÿ ¿“扡ºà “à π‡°≥±¡å “µ√∞“π ∑”„À‰â ¡‰à ¥√â ∫— °“√‡º¬·æ√à Õ¬à“߉√°Áµ“¡ °√¡«‘∑¬“»“ µ√å°“√·æ∑¬å ‰¥â¡’°“√ àÿ¡µ—«Õ¬à“ß ‡æË‘¡‡µ‘¡„π°√≥’∑Ë’æ∫«à“ µ”√—∫π—ÈπÊ¡’§ÿ≥¿“浓¡‡°≥±å∑Ë’°”Àπ¥·≈â« 2 √ÿàπº≈‘µ ‚¥¬°“√®—¥´È◊ÕÀ√◊Õ¢Õ§«“¡Õπÿ‡§√“–À宓° ‚√ß欓∫“≈»Ÿπ¬å ‚√ß欓∫“≈∑—Ë«‰ª ‡æÕË◊ µ√«® Õ∫§ÿ≥¿“æ‡æ¡Ë‘ ‡µ‘¡ ´÷ßË GREEN BOOK ‡≈¡à ∑’Ë 2 π’È °√¡«∑‘ ¬“»“ µ√°å “√·æ∑¬‰å ¥¥â ”‡ππ‘ °“√ ¡àÿ µ«— Õ¬“à ß‡æ¡‘Ë ‡µ¡‘ Õ°’ 2 √Õ∫¥«â ¬°π— ∑È—ßπÈ’ ‡æÕ◊Ë „À⬓∑’ºË ≈‘µ„πª√–‡∑»·≈–π”‡¢“â ®“°µ“à ߪ√–‡∑» ‰¥√â ∫— °“√µ√«® Õ∫§ÿ≥¿“æ·≈–‡º¬·æ√àÕ¬à“߇∑à“‡∑’¬¡°—π 8

Abstract The Department of Medical Sciences, Bureau of Drug and 9 Narcotic and Regional Medical Sciences Centers, has continuously implemented the ç Quality Assurance of Medicines under The Universal Health Care Coverage Schemeé. In Fiscal Year 2005, this task covered 36 items of modern and herbal products used in state hospitals nationwide. In addition, 10 items of modern products used in the community hospitals and primary health care units were inspected for compliance, with funds from The National Health Security Office. In this investigation, three rounds of sampling for some products were carried out to offer equal opportunities to locally-made and imported products. However, only the manufacturers holding 3 production lots of the pharmacopeial quality-approved products were reported in the present Green Book. This second publication also contains an annex compiling information cited from USP 29 - 2006, ç The reference tables of containers for dispensing capsules and tabletsé. The table indicates the proper use of containers in which the medicine that is repackaged should be dispensed. The Department of Medical Sciences expects comments and suggestions from users for the improvement of the next edition of Green Book

°µ‘ µ‘°√√¡ª√–°“» °√¡«∑‘ ¬“»“ µ√°å “√·æ∑¬å ¢Õ¢Õ∫§≥ÿ  ”π°— ß“π “∏“√≥ ¢ÿ ®ß— À«¥— ∫ÿ§≈“°√¢Õß‚√ß欓∫“≈∑—Èß„π·≈–πÕ° —ß°—¥¢Õß°√–∑√«ß “∏“√≥ ÿ¢ ·≈–  ”π—°ß“π§≥–°√√¡°“√Õ“À“√·≈–¬“ √«¡∑—Èß ”π—°ß“πÀ≈—°ª√–°—π ÿ¢¿“æ ·Ààß™“µ‘ µ≈Õ¥®π∫ÿ§≈“°√¢Õß°√¡«‘∑¬“»“ µ√å°“√·æ∑¬åºŸâ¥”‡π‘π°“√ µ√«®«‘‡§√“–Àå ∑’Ë„À⧫“¡√à«¡¡◊Õ·≈– π—∫ πÿπ„π°“√¥”‡π‘π‚§√ß°“√ª√–°—π §ÿ≥¿“欓 ªïß∫ª√–¡“≥ æ.». 2548 ®π ”‡√Á®≈ÿ≈à«ß¥â«¬¥’·≈–‰¥â¢âÕ¡Ÿ≈ §ÿ≥¿“æº≈‘µ¿—≥±å¬“‡º¬·æ√à„π‡Õ° “√‡≈à¡π’È 10

11

12

¬“ªØ‘™«’ π– 13 - Cefaclor capsule - Cefaclor suspension - Cefdinir capsule - Ceftazidime for injection - Cefuroxime for injection - Chloramphenical ear drop - Chloramphenical eye drop - Clindamycin injection - Co-trimoxazole oral suspension - Dicloxacillin sodium capsule - Norfloxacin tablet - Penicillin V potassium dry syrup - Penicillin V potassium tablet - Roxithromycin tablet

¬“ªØ‘™«’ π– Cefaclor capsule (‡´ø“§≈Õ√å ™π‘¥·§ª´≈Ÿ ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification ) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient ) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation ) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution ) ∫√‘…—∑∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±å§—¥‡≈Õ◊ ° √“¬™ÕË◊ ºŸâº≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ·√π·∫ä°´’Ë ·≈∫Õ√“∑Õ√’Ë å 1C 235/41 Vercef MR 375 14 Ranbaxy Lab, India ‚Õ≈‘§ (ª√–‡∑»‰∑¬) 1A 105/32 Distaclor 250 Olic (Thailand) Limited

¬“ªØ™‘ ’«π– Cefaclor suspension 125 mg/ 5 ml (‡´ø“§≈Õ√å ™π‘¥π”È ·¢«πµ–°Õπ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification ) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient ) - §à“§«“¡‡ªìπ°√¥ - ‡∫  (pH ) - Deliverable Volume ∫√…‘ —∑∑ºË’ à“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈◊Õ° √“¬™Ë◊ÕººâŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â 15 Manufacturer Reg .No. Trade name 1C 109/44 Õ’‰≈ ≈‘≈≈’Ë Distaclor Eli Lilly , Italy 1C 344/40 Vercef ·√π·∫ä°´’Ë ≈“∫Õ√“∑Õ√’Ë å Ranbaxy Lab, India

¬“ªØ‘™’«π– Cefdinir capsule 100 mg (‡´ø¥‘‡π¬’ √å ™π¥‘ ·§ª´≈Ÿ ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ( µ“¡«‘∏’·≈–¡“µ√∞“π∑–‡∫’¬πµ”√—∫¬“) - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√‘…∑— ∑ºË’ à“π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈◊Õ° √“¬™ÕË◊ ºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name øŸ®‘´“«“ ø“√å¡“´Ÿµ‘§Õ≈ 1 B 4/40 (N) Omnicef Fujisawa Pharmaceutical Co.,Ltd. Japan 16 ß∫ª√–¡“≥ :  ”π°— ß“πÀ≈°— ª√–°—π ÿ¢¿“æ·Ààß™“µ‘

¬“ªØ™‘ «’ π– Ceftazidime for injection 1 Gm (‡´øµ“´¥‘ ’¡™π¥‘ ºß ”À√—∫©’¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - §à“§«“¡‡ªìπ°√¥-¥à“ß (pH) - ª√‘¡“≥ Pyridine ∫√‘…—∑∑Ë’º“à π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈◊Õ° √“¬™ÕË◊ ºâºŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ·Õµ·≈𵑧 ≈“∫Õ√“∑Õ√’ å 1A 219/42 Forzid 17 Atlantic Laboratories Co.,Ltd 1A1220/43 Ceftum 1A 2/40 Cef-4 𑥓 ø“√å¡“ 1A 33/43 Fortadim Nida Pharma Inc., Ltd. 1C 75/46 Fortum 1A 355/43 Zeftam MH  ¬“¡‡¿ —™ Siam Bheasach Co., Ltd. ¬Ÿ¡’¥â“ Umeda Company Ltd. ·°≈Á°‚´ ¡‘∑‰§≈åπ, Õ‘µ“≈’ Glaxo Smith Kline S.P.A.,Italy ‡ÕÁ¡ ·Õπ¥å ‡Õ™ ·¡π·Ÿ ø§‡®Õ√‘ß M&H Manufacturing Co.,Ltd

¬“ªØ™‘ ’«π– Cefuroxime for injection 750 mg (‡´ø‚Ÿ √´’¡  ”À√∫— ©’¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ(Weight variation) - §à“§«“¡‡ªìπ°√¥-¥à“ß (pH) - °“√À“ª√‘¡“≥πÈ” (Water) - Constituted solutions (completeness and clarity of solution) ∫√…‘ ∑— ∑˺’ “à π¡“µ√∞“πµ“¡‡°≥±å§—¥‡≈◊Õ° √“¬™◊ËÕººâŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name ‰∫‚Õ·≈∫ 1A 516/36 Cefamar Biolab Co., Ltd. Zinacef Furoxime ·°≈Á°‚´  ¡‘∑ ‰§≈åπ 1C 51/46 Zonef 18 Glaxo Smith Kline S.P.A., Italy  ¬“¡‡¿ —™ 1A 276/34 Siam Bheasach Co., Ltd. ¬Ÿπ‘´—π ≈“∫Õ√“∑Õ√’Ë å 1A 420/44 Unison Laboratories Co., Ltd.

¬“ªØ‘™’«π– Chloramphenicol ear drop (§≈Õ·√¡‡øπ‘§Õ≈ ™π¥‘ À¬Õ¥À)Ÿ À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification ) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient ) - §à“§«“¡‡ªìπ°√¥ - ‡∫  (pH ) - °“√µ√«® Õ∫§«“¡ª√“»®“°‡™◊ÈÕ (Sterility Test ) - ª√‘¡“≥ “√ ≈“¬µ—« (Degradation products) ∫√‘…—∑∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈◊Õ° √“¬™ËÕ◊ ººâŸ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â 19 Manufacturer Reg .No. Trade name 1A 1747/28 · ß‰∑¬°”ª–π’ Antibi - Otic Seng Thai Company 1A 1082/29 1% w/v  ’≈¡°“√·æ∑¬å Silmycetin Silom Medical Co.,Ltd 10 mg/ml

¬“ªØ‘™«’ π– Chloramphenicol eye drop 5 mg/ml (§≈Õ·√¡‡øπ‘§Õ≈ ™π‘¥À¬Õ¥µ“) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification ) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient ) - §à“§«“¡‡ªìπ°√¥ - ‡∫  (pH ) - °“√µ√«® Õ∫§«“¡ª√“»®“°‡™◊ÈÕ (Sterility Test ) - ª√‘¡“≥ “√ ≈“¬µ—« (Degradation product) ∫√…‘ ∑— ∑º’Ë “à π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈◊Õ° √“¬™Õ◊Ë ºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name  ’≈¡°“√·æ∑¬å 1A 1516/28 Silmycetin Silom Medical Co.,Ltd. 20 ∑’ æ’ ¥√—° å ≈“∫Õ√“∑Õ√’ å 1A 169/37 Archifen T. P. Drugs Laboratories (1969)

¬“ªØ‘™«’ π– Clindamycin injection 150 mg/ml (§≈‘π¥“¡¬— ´‘π ™π‘¥©’¥) À—«¢âÕµ√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §«“¡‡ªìπ°√¥-‡∫  (pH) - °“√µ√«® Õ∫ Particulate matter ∫√…‘ —∑∑ºË’ à“π¡“µ√∞“πµ“¡‡°≥±å§—¥‡≈◊Õ° √“¬™◊ËÕºŸâº≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name ·Õ≈ ∫’ ‡Õ  ·≈∫ 1A 915/43 Clinoltt-p L.B.S. Lab Ltd., Part. 1 A 78/46 Rosil injection 21  ¬“¡‡¿ —™ Siam Bheasach Co., Ltd ß∫ª√–¡“≥ :  ”π—°ß“πÀ≈—°ª√–°π—  ¢ÿ ¿“æ·Ààß™“µ‘

¬“ªØ™‘ «’ π– Co-trimoxazole oral suspension (‚§‰µ√¡Õä °´“‚´≈ ™π‘¥πÈ”·¢«πµ–°Õπ ”À√∫— √∫— ª√–∑“π) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient ) - §à“§«“¡‡ªìπ°√¥ - ‡∫  (pH) ∫√…‘ ∑— ∑’˺“à π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈Õ◊ ° √“¬™◊ÕË ºâºŸ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name Õߧ尓√‡¿ —™°√√¡ - Co-Trimoxazole Government Pharmaceutical 40,200 mg/ml Organization 22

¬“ªØ™‘ ’«π– Dicloxacillin sodium capsule (‰¥§≈Õ°´“´‘≈‘π ‚´‡¥’¬¡™π¥‘ ·§ª´≈Ÿ ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ(Weight variation) ∫√…‘ —∑∑’ºË à“π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈◊Õ° √“¬™◊ÕË ººŸâ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name 𑥓 ø“√å¡“ 1A 2010/30 Dicloxin-250 Nida Pharma Inc., Ltd. Õߧ尓√‡¿ —™°√√¡ 1A 6/47 Dicloxacillin 250 23 Government Pharmaceutical Organization

¬“ªØ‘™«’ π– Norfloxacin tablet (πÕ√åø≈Õ°´“´π‘ ™π¥‘ ‡¡Á¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√‘…∑— ∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈◊Õ° √“¬™ËÕ◊ ºŸâº≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name Õߧ尓√‡¿ —™°√√¡ 1A 208/46 Norfloxacin-200 Government Pharmaceutical 1A 209/46 Norfloxacin-400 Organization ‚æ≈‘ø“√å¡ 1A 104/31 Norflocin-100 24 Polipharm Co., Ltd. Norxacin-100  ¬“¡‡¿ —™ 1A 508/31 Norxacin-400 Siam Bheasach Co., Ltd. 1A 416/33 ¬Ÿπ‘´—π ≈“∫Õ√“∑Õ√’Ë å 1A 861/41 Rexacin-400 Unison Laboratories Co., Ltd.

¬“ªØ‘™«’ π– Penicillin V potassium dry syrup 125 mg /5 ml (‡æππ´‘ ‘≈‘π«’‚ª·µ ‡´Ë’¬¡ ™π‘¥‰´√∫— ·Àßâ ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“§«“¡‡ªìπ°√¥ - ‡∫  (pH ) ∫√…‘ —∑∑º’Ë à“π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈◊Õ° √“¬™◊Ëպ⟺≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Trade name Manufacturer Reg .No. Pen V ‡¬π‡πÕ√—≈ ¥√—° ‡Œâ“ å 1A 381/27 25 General Drugs House Co., Ltd. Phenopen 1A 799/31 ‚Õ ∂ Õ‘π‡µÕ√å ·≈∫∫Õ√“∑Õ√’Ë å 1A 566/31 Semicillin Osoth Inter Lab. Co., Ltd. æÕπ¥å ‡§¡‘§Õ≈ å 1A 609/33 Pener - V2 Pondûs Chemicals (Thailand) 1A 1375/30 Pener -V2 ¬πŸ ‘´—π ≈“∫Õ√“∑Õ√’Ë å Unison Laboratories Co.,Ltd.

¬“ªØ‘™’«π– Penicillin V potassium tablet (‡æππ´‘ ≈‘ π‘ «‚’ ª·µ ‡´Ë¬’ ¡ ™π¥‘ ‡¡Á¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√…‘ ∑— ∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈◊Õ° √“¬™◊Ëպ⺟ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name Õߧ尓√‡¿ —™°√√¡ 1A 109/43 Penicillin V 125 Government Pharmaceutical 1A 110/43 Penicillin V 250 Organization 26

¬“ªØ‘™«’ π– Roxithromycin tablet 150 mg (√Õ°´‘‚∑√¡¬— ´‘π ™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√°√–®“¬µ—«¢Õ߇¡Á¥¬“ (Disintegration) ∫√…‘ ∑— ∑Ë’º“à π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈Õ◊ ° √“¬™Õ◊Ë ºâŸº≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â 27 Manufacturer Reg .No. Trade name 1A 354/37 ‰∫‚Õ·≈∫ 1A 329/46 Roxcin Biolab Co., Ltd. Roxtrocin ‡°√Á∑‡µÕ√å ø“√å¡“ 1A 431/41 Greater Pharma Ltd., Part 1A 161/45 Neroxin 1A 198/36 Roxithro 𑫉≈øá ø“√å¡“ Rothricin New Life Pharma Co., Ltd. 1A 125/40 1A 70/41 Roxthrin ¡‘≈≈‘‡¡¥ Roxthrin Millimed Co., Ltd.  ¬“¡‡¿ —™ Siam Bheasach Co., Ltd. ‡¿ —™°√√¡»√’ª√– ‘∑∏å Sriprasit Dispensary ROP. ∑’ ‚Õ ø“√å¡“ T.O.Pharma Co.,Ltd.

28

¬“√°— …“‚√§À«— „® ≈¥§«“¡¥π— ‚≈À‘µ - Captopril tablet - Isosorbide dinitrate tablet - Nifedipine solf capsule - Nifedipine extended release tablet - Propranolol HCl film coated tablet 29

¬“√°— …“‚√§À—«„® ≈¥§«“¡¥π— ‚≈À‘µ Captopril tablet (·§æ‚µæ√‘≈ ™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - §«“¡ ¡Ë”‡ ¡Õ¢Õߪ√¡‘ “≥µ«— ¬“„π·µ≈à –Àπ«à ¬(Contentuniformity) - °“√µ√«® Õ∫ Related substances ∫√‘…—∑∑’ºË “à π¡“µ√∞“πµ“¡‡°≥±å§—¥‡≈Õ◊ ° √“¬™Ë◊ÕººŸâ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name ∫√‘ µÕ≈ ‰¡‡¬Õ√å  §«‘ªªá 1C 184/34 Capoten-25 Bristol-Myers Squibb, Australia 1C 249/34 Capoten-12.5 30 √’‡¡¥‘°“ 1C 130/34 Epsitron Remedica Ltd., Cyprus

¬“√°— …“‚√§À«— „® ≈¥§«“¡¥—π‚≈À‘µ Isosorbide dinitrate tablet (‰Õ‚´´Õ√∫å “¬ ‰¥‰π‡∑√∑ ™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - §«“¡ ¡Ë”‡ ¡Õ¢Õߪ√¡‘ “≥µ«— ¬“„π·µ≈à –Àπ«à ¬ (Content uniformit ∫√…‘ ∑— ∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈Õ◊ ° √“¬™◊ÕË ºâŸº≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ‡∫Õ√å≈‘π ø“√å¡“´µŸ ‘§Õ≈ Õ‘π¥— ∑√’Ë 1A 330/41 Isotrate-10 Berlin Pharmaceutical Industry Ltd., Part. 1A 2030/30 Isobinate-10 ‡¬π‡πÕ√—≈ ¥√—° å ‡Œâ“ å 1A 1092/41 Angitrit-5 General Drugs House Co.,Ltd. 1C 936/29 Isorem-10 ‚Õ≈‘§ (ª√–‡∑»‰∑¬) Olic (Thailand) Ltd. 31 Remedica Ltd., Cyprus (ºŸâ·∑π®”Àπà“¬ : ø“√å¡“·≈π¥å)  ¬“¡‡¿ —™ 1A 593/42 Hartsorb-5 Siam Bheasach Co., Ltd. Õߧ尓√‡¿ —™°√√¡ 1A 442/45 Isosorbide dinitrate-10 Government Pharmaceutical 1A 782/38 Corodil-10 Organization ∑’ ‚Õ ø“√å¡“ T.O Pharma.Co.,Ltd. ‰«‡Õ∑ ‡Õ‡¬√å  ·§π“¥“ 1C 194/40 Isordil-10 Wyeth-Ayert,Canada 1C 74/40 Isordil-5

¬“√°— …“‚√§À«— „® ≈¥§«“¡¥π— ‚≈Àµ‘ Nifedipine solf capsule (‰π‡ø¥ª‘ πï ™π‘¥·§ª´≈Ÿ πË‘¡) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - §«“¡ ¡Ë”‡ ¡Õ¢Õߪ√¡‘ “≥µ«— ¬“„π·µ≈à –Àπ«à ¬(Contentuniformity) - °“√µ√«® Õ∫ Related substances ∫√‘…∑— ∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈◊Õ° √“¬™ÕË◊ ººâŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name J.B. Chemicals & Pharmaceuticals, 1C 54/46 Nicardia-5 India Nelapine-10 Nelapine-5 (ºŸâ·∑π®”Àπà“¬ : ®’ ‰Õ ‡Õ  ø“√å¡“) 32 ‡¡¥‘·§ª 1A 263/30 Medicap Co., Ltd. 1A 262/30 Torrent Pharm. Ltd., India 1C 347/30 Calcigard-5 Calcigard-10 (ºâŸ·∑π®”Àπà“¬ : ¬Ÿ‡π’¬π‡¡¥‘§Õ≈) 1C 575/29

¬“√°— …“‚√§À—«„® ≈¥§«“¡¥π— ‚≈À‘µ Nifedipine extended release tablet (‰π‡ø¥‘ªπï ™π‘¥‡¡¥Á ÕÕ°ƒ∑∏Ïπ‘ “π) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) °“√µ√«® Õ∫ Related substances ∫√‘…∑— ∑ºË’ à“π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈Õ◊ ° √“¬™◊ËÕººŸâ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Trade name Manufacturer Reg .No. Nifedipin- SR ‡¡Õ√å§ 1C 129/47 Nifelat Merckle GmbH. Germany Nifelat-R 1C 519/30 Nifedipin-SR √’‡¡¥‘°“ 1C 13/41 Remedica Ltd., Cyprus 1C 160/42 Nelapine-SR  µ“¥“ ø“√å¡“´µŸ ‘§Õ≈ 33 Stada Pharmaceutical, GmbH. ‡∫Õ√å≈‘π ø“√å¡“´µŸ ‘§Õ≈ Õ‘π¥— ∑√’Ë 1A 463/42 Berlin Pharmaceutical Industry Co.,Ltd.

¬“√°— …“‚√§À—«„® ≈¥§«“¡¥π— ‚≈Àµ‘ Propranolol HCl film coated tablet (‚æ√æ√“‚π≈Õ≈ ™π‘¥‡¡Á¥‡§≈Õ◊ ∫ø≈î ¡å ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) -§«“¡ ¡Ë”‡ ¡Õ¢Õߪ√¡‘ “≥µ«— ¬“„π·µ≈à –Àπ«à ¬(Contentuniformity) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√‘…—∑∑ºË’ à“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈Õ◊ ° √“¬™Õ◊Ë ºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name Õߧ尓√‡¿ —™°√√¡ 1A 346/43 Propranolol 10 Government Pharmaceutical 1A 474/44 Propranolol 40 Organization 34 ‡∫Õ√å≈‘π ø“√å¡“´µŸ ‘§Õ≈ Õ‘π¥— ∑√’Ë 1A 145/32 Betalol 10 Berlin Pharmaceutical Industry Co.,Ltd. 1 A 120/32 Betalol 40

¬“·°âª«¥ ≈¥‰¢â µâ“π°“√Õ°— ‡ ∫ §≈“¬°≈“â ¡‡πÈÕ◊ - Aspirin tablet /enteric coated table (‡æ¡‘Ë ‡µ‘¡‡≈à¡·√°) - Diclofensc diethylammonium gel - Ibuprofen tablet - Naproxen tablet - Tolperisone HCI tablet 35

¬“·°âª«¥ ≈¥‰¢â µ“â π°“√Õ°— ‡ ∫ §≈“¬°≈“â ¡‡πÈÕ◊ Aspirin tablet / enteric coated tablet (·Õ ‰æ√‘π™π¥‘ ‡¡¥Á ·≈–™π‘¥‡¡¥Á ‡§≈Õ◊ ∫ø≈î ¡å ‡Õπ‡∑Õ√§‘ ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - ª√‘¡“≥ “√ ≈“¬µ—«(Degradation product) ∫√‘…—∑∑’˺“à π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈Õ◊ ° √“¬™Õ◊Ë ºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg .No. Trade name Àâ“ߢ“¬¬“ Õ—ß°ƒ…µ√“ߟ 1A1693/28 Aspirin 325 mg The British Dispensary (LP) Co.,Ltd 1A 40/27 Aspirin Pediatric 81 mg ‚Õ≈‘§ (ª√–‡∑»‰∑¬) 1A1287/41 Aspent-M 60 mg 36 Olic (Thailand) Co.,Ltd. 1A1313/41 Aspent 300 mg ‚Õ ∂ Õπ‘ ‡µÕ√å ·≈∫∫Õ√“∑Õ√ ’Ë å 1A764/41 B-Aspirin 60 mg Osoth Inter Laboratories Co.,Ltd ∑’ ‚Õ ‡§¡‘§—≈ å 1A40/42 Anassa 60 mg T.O Chemicals (1979) Co.,Ltd.

¬“·°âª«¥ ≈¥‰¢â µâ“π°“√Õ—°‡ ∫ §≈“¬°≈â“¡‡πÈÕ◊ Diclofenac diethylammonium gel BP, 1 g/100g (‰¥‚§≈ø·ï π§ ‰¥‡Õ∑∑‘≈·Õ¡‚¡‡π¬’ ¡ ™π¥‘ ‡®≈) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - °“√µ√«® Õ∫ Related substances ∫√‘…—∑∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈◊Õ° √“¬™ÕË◊ ºŸâº≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â 37 Manufacturer Reg .No. Trade name - Õߧ尓√‡¿ —™°√√¡ Antenac Government Pharmaceutical 1A 532/40 Organization 1A 361/38 Difelene Dosanac ‰∑¬π§√æ—≤π“ 1A 178/36 Thai Nakorn Patana Co., Ltd. Volta  ¬“¡‡¿ —™ Siam Bheasach Co., Ltd. ∑’ ·¡π ø“√å¡“ T. Man Pharma

¬“·°âª«¥ ≈¥‰¢â µâ“π°“√Õ—°‡ ∫ §≈“¬°≈“â ¡‡πÈÕ◊ Ibuprofen tablet (‰Õ∫‚Ÿ æ√‡øπ ™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - °“√µ√«® Õ∫ Related substances ∫√…‘ —∑∑ºË’ “à π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈◊Õ° √“¬™ËÕ◊ ººâŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ∑’ ‚Õ ‡§¡‘§—≈ å 1A 464/33 Ibrofen-400 T.O.Chemicals (1979) Co., Ltd. 1 A 336/33 Ibrofen -200 ∫Ÿ∑ å 1A 1106/40 Nurofen-400 Boots Co., Ltd 1 A 271/39 Nurofen-200 ‡¿ —™°√√¡π§√æ—≤π“ 1A 376/36 Probufen-400 Nakornpatana Pharm Co., Ltd. ‰∑¬π§√æ—≤π“ 1A 324/39 Duran-400 Thai Nakorn Patana Co., Ltd. 38 ‡°√Á∑‡µÕ√å ø“√å¡“ 1A 344/46 Greatofen-400 Greater Pharma Ltd., Part Õߧ尓√‡¿ —™°√√¡ - Bunofen-200 Government Pharmaceutical Organization ¡‘≈≈‘‡¡¥ 1A 160/45 P-Fen-400 Millimed Co., Ltd., 𑥓 ø“√å¡“ 1A 379/38 Buprofen-200 Nida Pharma Inc., Ltd. ø“√å¡“ —πµå ≈“∫Õ√“∑Õ√’Ë å 1A 302/35 Cefen-400 Pharmasant Lab.Co., Ltd. 1A 128/35 Cefen-200 1A 538/44 Umafen-200 ¬Ÿ¡’¥â“ 1A 667/44 Umafen-400 Umeda Co., Ltd.

¬“·°ªâ «¥ ≈¥‰¢â µâ“π°“√Õ°— ‡ ∫ §≈“¬°≈â“¡‡πÕÈ◊ Naproxen sodium tablet (𓂪√‡´π‚´‡¥¬’ ¡ ™π‘¥‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√…‘ ∑— ∑’˺à“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈Õ◊ ° √“¬™Ë◊ÕºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Trade name Manufacturer Reg .No. Soproxen 250 ‡∫Õ√å≈‘π ø“√å¡“´Ÿµ‘§Õ≈ Õ‘π¥— ∑√’Ë 1A 144/32 Synflex 275 39 Berlin Pharm. Industry Ltd., Part. 1A 148/42 1A 129/35 Annoxen-S 275 ‚Õ≈‘§ (ª√–‡∑»‰∑¬) Olic (Thailand) Ltd.  ¬“¡‡¿ —™ Siam Bheasach Co., Ltd.

¬“·°âª«¥ ≈¥‰¢â µâ“π°“√Õ°— ‡ ∫ §≈“¬°≈“â ¡‡πÈ◊Õ Naproxen tablet (𓂪√‡´π™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) ∫√‘…∑— ∑’ºË à“π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈Õ◊ ° √“¬™ÕË◊ ººŸâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ‡∫ ´’Ë ·Õ√Õπ 1A 2188/30 Proxen - 250 Bessy Aron Co., Ltd. 40 Õߧ尓√‡¿ —™°√√¡ 1A 911/42 Naproxen - 250 Government Pharmaceutical Organization

¬“·°ªâ «¥ ≈¥‰¢â µ“â π°“√Õ—°‡ ∫ §≈“¬°≈“â ¡‡πÕÈ◊ Tolperisone HCl tablet, 50 mg (∑Õ≈‡æÕ√‘‚´π‰Œ‚¥√§≈Õ‰√¥å ™π¥‘ ‡¡¥Á ) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - ª√‘¡“≥ “√ ≈“¬µ—« (Degradation product) ∫√‘…∑— ∑’˺“à π¡“µ√∞“πµ“¡‡°≥±å§—¥‡≈Õ◊ ° √“¬™◊ËÕºŸâº≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Trade name Manufacturer Reg .No. Biocalm ‰∫‚Õ·≈∫ 1A 677/34 Mydocalm Biolab Co., Ltd. Soneriper Gedeon Richter Ltd., 1B 16/43 Spamus 41 Hungary Myoxan (ºŸâ·∑π®”Àπà“¬ : ∫.¬Ÿπ‘´—π ®”°—¥) 1A 907/43 1A 218/31 ø“√å¡“ —πµå ≈“∫Õ√“∑Õ√’ å Pharmasant Lap.Co.,Ltd. ∑’ ·¡π ø“√å¡“ T. Man Pharma Ltd., Part. ∑’ ‚Õ ø“√å¡“ 1A 179/39 T.O. Pharma Co., Ltd.

42

¬“√—°…“‚√§„π√–∫∫∑“߇¥π‘ Õ“À“√ - Domperidone oral suspension - Domperidone tablet - Hyoscine butylbromide coated tablet - Ranitidine tablet 43

¬“√°— …“‚√§„π√–∫∫∑“߇¥‘πÕ“À“√ Domperidone oral suspension, 1mg/ml (¥Õ¡‡æÕ√‘‚¥π ™π¥‘ πÈ”·¢«πµ–°Õπ ”À√∫— √∫— ª√–∑“π) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“§«“¡‡ªìπ°√¥-‡∫  (pH) ∫√‘…—∑∑º’Ë “à π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈Õ◊ ° √“¬™ËÕ◊ ºâºŸ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ·Õ≈ ∫’ ‡Õ  ≈“∫Õ√“∑Õ√ ’ å 1A 587/31 Doperan L.B.S. Lab Ltd. ‚æ≈‘ø“√å¡ 1A 752/38 Domperdone Polipharm Co., Ltd. 1A 554/39 Pondperdone æÕπ¥å ‡§¡‘§Õ≈ å Pondûs Chemicals (Thailand) 44  ¬“¡ ‡¡¥‘·§√å 1A 837/32 Dany Siam Medicare Co., Ltd. ∑’ ·¡π ø“√å¡“ 1A 863/30 Dominox T.Man Pharma Ltd., Part ∑’ ‚Õ ø“√å¡“ 1A 901/43 Motidom T.O. Pharma Co., Ltd. ¬πŸ ‘´—π ≈“∫Õ√“∑Õ√’Ë å 1A 143/41 Rabugen Unison Laboratories Co., Ltd.

¬“√°— …“‚√§„π√–∫∫∑“߇¥π‘ Õ“À“√ Domperidone tablet,10 mg (¥Õ¡‡æÕ√‘‚¥π™π¥‘ ‡¡Á¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - °“√µ√«® Õ∫ Related substances ∫√‘…∑— ∑ºË’ “à π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈Õ◊ ° √“¬™◊Ëպ⟺≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™◊ËÕ°“√§â“ 45 Manufacturer Reg .No. Trade name 1A245/40 ∫“ß°Õ° ·≈∫ ·Õπ¥å §Õ ‡¡µ‘§ Domper-M Bangkok Lab & Cosmetic Co, 1A752/44 1A292/32 Mirax-M ‡∫Õ√å≈‘π ø“√å¡“´Ÿµ‘§Õ≈ Õ‘π¥— ∑√’Ë 1A262/41 Mirax Berlin Pharmaceutical Industry. Ltd., Part Mocydone-M 1A326/45 ø“√å¡“ —πµå ≈“∫Õ√“∑Õ√’Ë å Stillium Pharmasant Laboratories Co.,Ltd. 1A252/43 𑥓 ø“√å¡“ Domp-M Nida Pharma Inc.Co., Ltd. 1A86/40 ™ÿ¡™π‡¿ —™°√√¡ 1A1213/41 Moridon Community Pharmacy Public Co.Ltd. 1A58/35 Moridon-M 𑫉≈øá ø“√å¡“ 1A2501/29 Molax-M New Life Pharma Co., Ltd. 1A2252/29 Molax  ¬“¡‡¿ —™ 1A460/38 Dominox Siam Bheasach Co., Ltd. 1A350/30 ∑’·¡π ø“√å¡“ 1A2028/30 Motidom-M T. Man Pharma Ltd.,Part Motidom Dolium ∑’‚Õ ‡§¡‘§—≈ å T. O. Chemicals (1979) Ltd. ¬Ÿ‚∑‡ªïô¬π Utopian Co., Ltd.

¬“√°— …“‚√§„π√–∫∫∑“߇¥‘πÕ“À“√ Hyoscine butylbromide coated tablet 10 mg (Œ¬— ÕÕ ´’π∫«‘ ∑‘≈‚∫√¡“¬¥å ™π‘¥‡¡Á¥‡§≈Õ◊ ∫øî≈å¡ / π”È µ“≈) À—«¢âÕµ√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation)  ”À√—∫ film coated - °“√°√–®“¬µ—«¢Õ߇¡Á¥¬“ (Disintegration) - °“√µ√«® Õ∫ Related substances ∫√‘…∑— ∑’˺“à π¡“µ√∞“πµ“¡‡°≥±§å —¥‡≈◊Õ° √“¬™ËÕ◊ ºâŸº≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ∫“ß°Õ° ·≈∫ ·Õπ¥å §Õ ‡¡µ§‘ 1 A101/38 Spascopan Myspa Bangkok Lab & Cosmetic Co., Ltd. Butyl ‡°√Á∑‡µÕ√å ø“√å¡“ 1 A355/44 Greater Pharma Co., Ltd. 46 ¡“´“·≈∫ 1 A942/40 Masa Lab Co., Ltd ¬Ÿ¡’¥“ 1 A 641/44 U-oscine Umeda Co., Ltd ¬Ÿπ‘´—π ≈“∫Õ√“∑Õ√’Ë å 1 A 525/42 Higan Unison Lab. Co., Ltd ß∫ª√–¡“≥ :  ”π°— ß“πÀ≈°— ª√–°—π ÿ¢¿“æ·Àßà ™“µ‘

¬“√—°…“‚√§„π√–∫∫∑“߇¥‘πÕ“À“√ Ranitidine tablet, 150 mg (√“π∑‘ ‘¥’π ™π‘¥‡¡Á¥) À—«¢âÕ∑’˵√«® Õ∫§ÿ≥¿“æ - °“√µ√«®æ‘ Ÿ®πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - §à“‡∫’ˬ߇∫π®“°πÈ”Àπ—°‡©≈’ˬ (Weight variation) - °“√≈–≈“¬¢Õßµ—«¬“ (Dissolution) - °“√µ√«® Chromatographic Purity ∫√…‘ ∑— ∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±å§¥— ‡≈Õ◊ ° √“¬™◊ÕË ººâŸ ≈µ‘ ‡≈¢∑–‡∫¬’ 𬓠™Õ◊Ë °“√§“â Manufacturer Reg .No. Trade name ‡∫Õ√≈å π‘ ø“√¡å “´µŸ §‘ Õ≈ Õπ‘ ¥ — ∑√’Ë 1A 67/33 Xanidine 47 Berlin Pharmaceutical Industry Ltd. 1A 24/27 Ranidine 1A 426/46 ‰∫‚Õ·≈∫ Utac Biolab Co. Ltd. ¡‘≈≈‘‡¡¥ Millimed Co., Ltd. ß∫ª√–¡“≥ : °√¡«∑‘ ¬“»“ µ√°å “√·æ∑¬å ·≈– ”π°— ß“πÀ≈—°ª√–°π—  ¢ÿ ¿“æ·Àßà ™“µ‘

48

¬“√—°…“‚√§„π√–∫∫∑“߇¥π‘ À“¬„® - Salbutamol inhaler - Triprolidine HCl and Pseudoephedrine HCl tablet - Terbutaline sulfate injection - Terbutaline sulfate tablet 49

¬“√°— …“‚√§„π√–∫∫∑“߇¥‘πÀ“¬„® Salbutamol inhaler (´≈— ∫Ÿ∑“¡Õ≈ ™π‘¥æπà ) À—«¢âÕµ√«® Õ∫§ÿ≥¿“æ (µ“¡µ”√“¬“ BP 2004 ·≈–∑–‡∫’¬π¬“) - °“√µ√«®æ‘ ®Ÿ πå‡Õ°≈—°…≥å (Identification) - ª√‘¡“≥µ—«¬“ ”§—≠ (Active ingredient) - °“√µ√«® Õ∫ Related substance ∫√‘…—∑∑Ë’ºà“π¡“µ√∞“πµ“¡‡°≥±§å ¥— ‡≈◊Õ° √“¬™ÕË◊ ºŸºâ ≈‘µ ‡≈¢∑–‡∫¬’ 𬓠™ÕË◊ °“√§“â Manufacturer Reg.No. Trade name Chiesi Farmaceutici S.p.A., Italy 1 B 2/45 Butovent (ºâŸ·∑π®”Àπà“¬ : ‚Õ≈‘§ ª√–‡∑»‰∑¬) Laboratorio Aldo-Union SA., Spain 1C 217/43 Buto-asma (º·âŸ ∑π®”Àπ“à ¬: ‡°√∑Á ‡µÕ√å ø“√å¡“) 50 ß∫ª√–¡“≥ :  ”π°— ß“πÀ≈—°ª√–°π—  ÿ¢¿“æ·Ààß™“µ‘